Page last updated: 2024-09-03

imatinib mesylate and Day Blindness

imatinib mesylate has been researched along with Day Blindness in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chan, CK; Mohamed, S; Szeto, SK; Tsang, CW1
Chopra, Y; Grover, AK; Ramzan, M; Yadav, SP1
Auffarth, GU; Kaiser, D; Khoramnia, R; Marx, S; Scheuerle, A; Sel, S; Tandogan, T1
Ghosh, B; Goel, N; Pangtey, B; Raina, UK; Thakar, M1
Arakawa, A; Kami, M; Kato, D; Kishi, Y; Kusumi, E; Miyakoshi, S; Morinaga, S; Murashige, N; Muto, Y; Taniguchi, S; Ueyama, J; Yuji, K1
Anupama, G; Attili, VS; Bapsy, PP; Govind Babu, K1

Other Studies

6 other study(ies) available for imatinib mesylate and Day Blindness

ArticleYear
Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
    European journal of ophthalmology, 2023, Volume: 33, Issue:1

    Topics: Animals; Chronic Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Retina; Retinal Diseases; Retinal Hemorrhage; Vision Disorders

2023
Isolated bilateral uveitis in child with hypereosinophilic syndrome.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7

    Topics: Benzamides; Child; Female; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome; Uveitis; Vision Disorders

2014
[Sudden bilateral decreased vision in a 14-year-old boy].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2017, Volume: 114, Issue:8

    Topics: Adolescent; Emergency Service, Hospital; Fundus Oculi; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Retinal Hemorrhage; Tomography, Optical Coherence; Vision Disorders; Vision, Binocular; Vision, Low

2017
Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2012, Volume: 16, Issue:4

    Topics: Adolescent; Allopurinol; Antineoplastic Agents; Benzamides; Bone Marrow; Drug Therapy, Combination; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Piperazines; Proto-Oncogene Proteins c-bcr; Pyrimidines; Retina; Retinal Neoplasms; Retinal Vein Occlusion; Vision Disorders; Visual Acuity

2012
Visual disturbance due to retinal edema as a complication of imatinib.
    Leukemia, 2004, Volume: 18, Issue:6

    Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Papilledema; Piperazines; Pyrimidines; Vision Disorders

2004
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
    International ophthalmology, 2007, Volume: 27, Issue:1

    Topics: Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Optic Neuritis; Piperazines; Prednisolone; Pyrimidines; Treatment Outcome; Vision Disorders

2007